Loading…
Loading…
OKLO does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for OKLO and 80,000+ other tickers.
See exactly how OKLO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for OKLO and 80,000+ other tickers.
Oklo Inc. develops advanced fission power plants to provide clean, reliable, and affordable energy at scale to customers in the United States. The company’s primary offering is the Aurora powerhouse, which is designed to produce between 15 and up to 75 megawatts of electricity. The company is also commercializing nuclear fuel recycling, fuel fabrication technology that can convert used nuclear fuel into usable fuel for its reactors, and the production of radioisotopes. The company has a strategic partnership with Blykalla AB for the development of advanced nuclear reactor technology and its…
Oklo stock has struggled to find its footing in 2026, with shares down 42% thus far. The stock price is approaching its 52-week low of $36.61.
Nuclear energy is a promising solution to AI's rising energy needs. SMR technology has high upside potential but also clear risks.
Massive demand for electricity has led to a nuclear renaissance, but it really hasn't hit the U.S. just yet.
NuScale Power and Oklo are leading SMR stocks. Picking between the two relies on one key decision.
I maintain my Buy rating of Oklo with my price target revised from $99 to $88 due to dilution. Q2 2026 demonstrated tangible execution progress: Groves achieved first criticality, Aurora-INL advanced, and Aurora-Ohio secured key agreements. My normalized EBITDA estimate rises modestly to $443 million, with improved confidence in risk-adjusted capacity for Ohio, INL, Fuel, and Isotopes.